AMSURG Corp. (NASDAQ: AMSG) today announced that it has launched its offering of approximately $880 million aggregate principal amount of senior unsecured notes due 2022 (the "Notes"). The closing of the offering of the Notes is conditioned upon the closing of AMSURG's previously announced acquisition of Sheridan Healthcare (the "Sheridan Transaction").
AMSURG intends to use the net proceeds from this private offering, together with its recently announced registered public offerings of common stock and 5.250% Mandatory Convertible Preferred Stock, additional debt financing and cash on hand, to finance the cash consideration to be paid to consummate the Sheridan Transaction, as well as repay borrowings under AMSURG's existing revolving credit facility, repay the outstanding balance of its senior secured notes due 2020 and pay fees and expenses related to the Sheridan Transaction.